Lack of Association of the NPAS2 Gene Ala394Thr Polymorphism (rs2305160:G>A) with Risk of Chronic Lymphocytic Leukemia
Authors:
- Adeela ShahidASAdeela Shahid
- Hafeez UllahHUHafeez Ullah
- Saqib MahmoodSMSaqib Mahmood
Open Access
- 15 September 2014
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (17) , 7169-7174
Abstract
Lack of Association of the NPAS2 Gene Ala394Thr Polymorphism (rs2305160:G>A) with Risk of Chronic Lymphocytic Leukemia NPAS2;rs2305160;polymorphism;genotypes;cancer;CLL; Background: NPAS2 is a product of the circadian clock gene. It acts as a putative tumor suppressor by playing an important role in DNA damage responses, cell cycle control and apoptosis. Chronic lymphocytic leukemia (CLL) appears to be an apoptosis related disorder and alteration in the NPAS2 gene might therefore be directly involved in the etiology of CLL. Here, the Ala394Thr polymorphism (rs2305160:G>A) in the NPAS2 gene was genotyped and melatonin concentrations were measured in a total of seventy-four individuals, including thirty-seven CLL cases and an equal number of age- and sex-matched healthy controls in order to examine the effect of NPAS2 polymorphism and melatonin concentrations on CLL risk in a Pakistani population. Materials and Methods: Genotyping of rs2305160:G>A polymorphism at NPAS2 locus was carried out by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Melatonin concentrations were determined by enzyme linked immunosorbent assay (ELISA). Statistical analysis was performed using Statistical Package for Social Sciences software. Results: Our results demonstrated no association of the variant Thr genotypes (Ala/Thr and Thr/Thr) with risk of CLL. Similarly, no association of rs2305160 with CLL was observed in either females or males after stratification of study population on a gender basis. Moreover, when the subjects with CLL were further stratified into shift-workers and non-shift-workers, no association of rs2305160 with CLL was seen in either case. However, significantly low serum melatonin levels were observed in CLL patients as compared to healthy subjects (p0.05) of the rs2305160 polymorphism of the NPAS2 gene with melatonin levels in any of the groups. Conclusions: While low melatonin levels and shift-work can be considered as one of the risk factors for CLL, the NPAS2 rs2305160 polymorphism does not appear to have any association with risk of CLL in our Pakistani population.Keywords
This publication has 25 references indexed in Scilit:
- Shift work and cancer – considerations on rationale, mechanisms, and epidemiologyScandinavian Journal of Work, Environment & Health, 2010
- Evidence for an Overlapping Role of CLOCK and NPAS2 Transcription Factors in Liver Circadian OscillatorsMolecular and Cellular Biology, 2008
- Variants in circadian genes and prostate cancer risk: a population-based study in ChinaProstate Cancer and Prostatic Diseases, 2007
- Tumor Suppression and Circadian FunctionJournal of Biological Rhythms, 2007
- CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clockNature Neuroscience, 2007
- A CLOCK-less clockTrends in Cell Biology, 2006
- The circadian clock: pacemaker and tumour suppressorNature Reviews Cancer, 2003
- The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In VivoCell, 2002
- Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysisJournal of Molecular Medicine, 1999
- Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinationsClinica Chimica Acta, 1992